Breast Imaging Market Report
RA00277
Breast Imaging Market, by Technology (Ionizing technology, Non-ionizing technology), Geography (North America, Europe, Latin America, Middle East Africa, Asia Pacific) Global Opportunities, Challenges, and Industry Forecast, 2020-2027
Breast Imaging Market Analysis:
Breast imaging is a diagnostic technique used to identify the lesions which are an indication of cancer cells in the breast. Breast imaging is usually done prior to biopsy. Breast imaging process will capture images of breasts for the identification of breast cancers and has undergone many advancements in the last decade. It uses low energy X-rays to screen and identify any presence of calcifications and hard masses in the breast, which will detect cancer in early stages.
The breast imaging market is rallying towards tremendous growth due to increased prevalence of cancers.
Breast cancer is foreseen to ascend with drastic changes in lifestyle, and the diminishing habit of breastfeeding, particularly in developed nations. Consequently, the demand for these imaging products is predicted to drive the market in the forecast period. Innovative advancements, such as molecular breast imaging, optical imaging, digital mammogram, electrical impedance imaging, and tomosynthesis, are currently accelerating the market growth. Government initiatives are predicted to drive the market in the forecast period. For instance, awareness generating projects and providing funding for R&D in the field of breast cancer are foreseen to support the breast cancer market. The National Cancer Institute of the U.S. contributed around 559 million on the research of breast cancer in 2013, though, in 2013, the UK government initiated a campaign "Be clear on cancer," which helped in spreading awareness and knowledge about the hazardous factors, preventive measures, and early detection of breast cancer.
Strict regulatory framework and dose management for radiation therapy are the challenges that this market will face.
Radiation dose management, product recalls stringent regulatory policies, growing adoption of refurbished systems, and errors in breast cancer screening are predicted to hinder the market growth in the forecasted period.
Extensive R&D trails and technological advancements are the opportunities for breast imaging market globally.
The greatest opportunity in the breast imaging market is the latest advancements in technology in medical sector. The rise in investments from both the non-government organizations and governments is leading the demand in the market. Globalization and urbanization are the factors that are boosting the growth opportunities in breast imaging market. The extended R&D trials, increased spending on healthcare and advanced equipment in the hospitals and diagnostic centres are the opportunities that the investors can seize in the forecasted period.
Breast Imaging Market, by Technology:
Tomosynthesis is expected to show lucrative growth in the forecast period in the breast imaging market.
The technology segment is divided into ionizing and non-ionizing technologies. The ionizing technology is further sub-divided into segments such as full-field digital mammography, electric impedance tomography, cone-beam computed tomography, position emission tomography, position emission mammography and computed tomography (PET-CT), 3D breast tomosynthesis, analog mammography and molecular breast specific gamma imaging. The non-ionizing technology segment includes breast MRI, breast thermography, optical imaging, breast ultrasound, computerized whole-breast ultrasound. The mammography-based devices currently contributed most to the market with a major market share. But, the tomosynthesis is expected to be a lucrative segment in the expected period due to its higher precision and reliable results. Tomosynthesis takes numerous pictures of the breast simultaneously in few seconds. While the mammography devices cannot take numerous images in such a short time due to which tomosynthesis is predicted to drive the market in the forecast period.
Breast Imaging Market, by Region:
Asia Pacific region is anticipated to show greater demand in the estimated period.
North America region is predicted to have the highest revenue generating market in the forecast period. The advanced healthcare infrastructure in this region and the presence of repayment facilities over clinical treatments, encouraged the use of breast imaging instruments. In addition, the decent of the chronic diseases in this region is considerably higher than the worldwide normal, which is contributing to the development of this region profoundly. The Asia Pacific market is expected to observe the quickest growth in the estimated period. Strong government regulation helps to improve the health care facilities alongside financial support is predicted to drive the regional market in the forecast period.
Key Players in Breast Imaging Market:
The major market players in breast imaging are GE Healthcare, Hologic, Inc., Gamma Medica, Inc., Philips Healthcare, Fujifilm Holdings Corp., SonoCine, Inc., Toshiba Corporation, Dilon Technologies, Inc., Siemens Healthcare, and Aurora Imaging Technology, Inc.
|
Aspect |
Particulars |
|
Historical Market Estimations |
2018-2019 |
|
Base Year for Market Estimation |
2019 |
|
Forecast timeline for Market Projection |
2020-2027 |
|
Geographical Scope |
North America, Europe, Asia Pacific, and LAMEA |
|
Segmentation by Technology |
|
|
Key Countries Covered |
U.S. Canada, Germany, France, Spain, Russia, Japan, China, India, South Korea, Australia, Brazil, Latin America, Middle East, and Africa. |
|
Key Companies Profiled |
|
Q1. Which factors are projected to guide the breast imaging market globally?
A. Rising breast cancers in developed countries and awareness among people are the factors that are projected to guide the breast imaging market globally.
Q2. Which is the geographical region which yields higher benefit for the Investors?
A. Asia pacific is expected to be the top geographical region, which will yield higher benefits for the investors in the forecasted period.
Q3. Which Technology segment can be tapped in the future for great opportunities?
A. The tomosynthesis segment can be tapped in the future for great opportunities as it takes multiple images simultaneously.
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Breast Imaging Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Breast Imaging Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Breast Imaging Market, By Distribution Channel
5.1. Overview
5.2 Ionizing
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Non Ionizing
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Research Dive Exclusive Insights
5.4.1 Market attractiveness
5.4.2 Competition heatmap
6. Breast Imaging Market, By Region
6.1 North America
6.1.1 U.S
6.1.1.1 Market size analysis, By Distribution Channel, 2020-2027
6.1.2 Canada
6.1.2.1 Market size analysis, By Distribution Channel, 2020-2027
6.1.3 Mexico
6.1.3.1 Market size analysis, By Distribution Channel, 2020-2027
6.1.4 Research Dive Exclusive Insights
6.1.4.1 Market attractiveness
6.1.4.2 Competition heatmap
6.2 Europe
6.2.1 Germany
6.2.1.1 Market size analysis, By Distribution Channel, 2020-2027
6.2.2 UK
6.2.2.1 Market size analysis, By Distribution Channel, 2020-2027
6.2.3 France
6.2.3.1 Market size analysis, By Distribution Channel, 2020-2027
6.2.4 Spain
6.2.4.1 Market size analysis, By Distribution Channel, 2020-2027
6.2.5 Italy
6.2.5.1 Market size analysis, By Distribution Channel, 2020-2027
6.2.6 Rest of Europe
6.2.6.1 Market size analysis, By Distribution Channel, 2020-2027
6.2.7 Research Dive Exclusive Insights
6.2.7.1 Market attractiveness
6.2.7.2 Competition heatmap
6.3 Asia-Pacific
6.3.1 China
6.3.1.1 Market size analysis, By Distribution Channel, 2020-2027
6.3.2 Japan
6.3.2.1 Market size analysis, By Distribution Channel, 2020-2027
6.3.3 India
6.3.3.1 Market size analysis, By Distribution Channel, 2020-2027
6.3.4 Australia
6.3.4.1 Market size analysis, By Distribution Channel, 2020-2027
6.3.5 South Korea
6.3.5.1 Market size analysis, By Distribution Channel, 2020-2027
6.3.6 Rest of Asia-Pacific
6.3.6.1 Market size analysis, By Distribution Channel, 2020-2027
6.3.7 Research Dive Exclusive Insights
6.3.7.1 Market attractiveness
6.3.7.2 Competition heatmap
6.4 LAMEA
6.4.1 Brazil
6.4.1.1 Market size analysis, By Distribution Channel, 2020-2027
6.4.2 Saudi Arabia
6.4.2.1 Market size analysis, By Distribution Channel, 2020-2027
6.4.3 UAE
6.4.3.1 Market size analysis, By Distribution Channel, 2020-2027
6.4.4 South Africa
6.4.4.1 Market size analysis, By Distribution Channel, 2020-2027
6.4.5 Rest of LAMEA
6.4.5.1 Market size analysis, By Distribution Channel, 2020-2027
6.4.6 Research Dive Exclusive Insights
6.4.6.1 Market attractiveness
6.4.6.2 Competition heatmap
7. Competitive Landscape
7.1 Top winning strategies, 2020-2027
7.1.1 By strategy
7.1.2 By year
7.2 Strategic overview
7.3 Market share analysis, 2020-2027
8. Company Profiles
8.1 Hologic, Inc.
8.1.1 Overview
8.1.2 Business segments
8.1.3 Product portfolio
8.1.4 Financial performance
8.1.5 Recent developments
8.1.6 SWOT analysis
8.2 GE Healthcare
8.2.1 Overview
8.2.2 Business segments
8.2.3 Product portfolio
8.2.4 Financial performance
8.2.5 Recent developments
8.2.6 SWOT analysis
8.3 Siemens Healthineers
8.3.1 Overview
8.3.2 Business segments
8.3.3 Product portfolio
8.3.4 Financial performance
8.3.5 Recent developments
8.3.6 SWOT analysis
8.4 Koninklijke Philips N.V.
8.4.1 Overview
8.4.2 Business segments
8.4.3 Product portfolio
8.4.4 Financial performance
8.4.5 Recent developments
8.4.6 SWOT analysis
8.5 Fujifilm Holdings Corporation
8.5.1 Overview
8.5.2 Business segments
8.5.3 Product portfolio
8.5.4 Financial performance
8.5.5 Recent developments
8.5.6 SWOT analysis
8.6 Canon Inc.
8.6.1 Overview
8.6.2 Business segments
8.6.3 Product portfolio
8.6.4 Financial performance
8.6.5 Recent developments
8.6.6 SWOT analysis
8.7 Aurora Healthcare US Corp.
8.7.1 Overview
8.7.2 Business segments
8.7.3 Product portfolio
8.7.4 Financial performance
8.7.5 Recent developments
8.7.6 SWOT analysis
8.8 Allengers
8.8.1 Overview
8.8.2 Business segments
8.8.3 Product portfolio
8.8.4 Financial performance
8.8.5 Recent developments
8.8.6 SWOT analysis
8.9 Dilon Technologies, Inc.
8.9.1 Overview
8.9.2 Business segments
8.9.3 Product portfolio
8.9.4 Financial performance
8.9.5 Recent developments
8.9.6 SWOT analysis
8.10 Planmed Oy
8.10.1 Overview
8.10.2 Business segments
8.10.3 Product portfolio
8.10.4 Financial performance
8.10.5 Recent developments
8.10.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
